Most of the attention in defense technology goes to the primes: the Lockheeds, the Raytheons, the big-platform builders. Science Applications International (SAIC) is quieter. It integrates systems, runs mission IT, supports the intelligence community, secures networks. Unglamorous work. And on Monday morning, the company reported a quarter that should force investors to pay attention.
Why This Stock Now
SAIC posted adjusted EPS of $3.01 for fiscal Q2 2027, exceeding the analyst consensus of about $2.31 by roughly 30%. That is not a rounding error driven by one favorable line item. Revenue rose 6.3% with organic growth at 5.3%. Adjusted EBITDA came in at $193 million at a 10.3% margin. Free cash flow was $131 million. Across every metric that matters for a government services contractor, SAIC outperformed.
Then management did something rarer: it raised guidance across the board. Full-year revenue guidance moved up to a range of $7.2 billion to $7.3 billion, with adjusted EBITDA guidance raised to $750 million to $755 million, implying margins of 10.3% to 10.5%. Free cash flow guidance stayed at greater than $600 million.
The Business
SAIC is a leading provider of technical, engineering, and enterprise IT services to the U.S. government, covering systems engineering and integration, mission support, cybersecurity, data analytics, and cloud solutions across defense, space, and national security. The work spans the full program lifecycle, which matters because it creates sticky, recurring revenue streams that are hard for competitors to displace.
The stickiness showed up in the numbers this quarter. On-contract growth ran at 9%. Programs won in fiscal 2025 and 2026 that ramped slowly are now producing.
Why Wall Street Is Paying Attention
Shares were volatile on Monday. SAIC touched $142.66 intraday, but the stock finished the day at $128.22, up about 1.8% from the prior close.
The transformation program has a name: Project ORBIT. Management says it is expected to generate about $150 million in annual run-rate savings, with a path to roughly 11% EBITDA margins by fiscal 2030. That compares with 10.3% today. The margin runway, if management executes, gives this stock a compounding story that does not require heroic assumptions about new contract wins.
Timing adds a layer the market may be underweighting. The federal fiscal year ends September 30, and as agencies work to obligate remaining funds, new opportunities surface and move quickly. September alone has historically accounted for roughly 14% of annual federal contract obligations, nearly three times the October rate. SAIC, with its existing contract base, is positioned to benefit from that spend in real time.
What Could Go Wrong
The bear case starts with the book-to-bill ratio. At 0.6 times for the quarter and 0.8 times on a trailing 12-month basis, SAIC is not yet replenishing its backlog at the rate it is consuming it. Management noted the quarterly figure was distorted by a delayed large recompete award, but investors who focus on backlog health will find reason for caution.
Organic growth guidance for the full year remains modest at negative 2% to flat, and the company assumes a continuing resolution for the next federal fiscal year, which could limit new-start opportunities. A prolonged CR or an actual government shutdown heading into October would pressure near-term revenue and award timing.
Valuation is not stretched, but it is no longer cheap after the post-earnings volatility. And the EPS year-over-year comparison carries a caveat: adjusted diluted EPS of $3.01 was down 17% from $3.63 in the year-ago quarter, primarily due to a favorable settlement in the prior period. The headline beat against consensus is real; the year-over-year decline is also real.
The Bottom Line
SAIC beat by about 30%, raised guidance to $7.2 billion to $7.3 billion in revenue, and sits near its 52-week high with the government’s heaviest contracting month directly ahead. The business compounds steadily rather than explosively, which is precisely why it stays off most investors’ radar until a quarter like this one forces a rerating. The stock is not a momentum play. It is a quality compounder with a clear catalyst calendar and a margin expansion path that management has now earned some credibility to claim. For an investor seeking one stock with tangible near-term catalysts and a validated fundamental improvement, SAIC deserves serious consideration today.
